Sökning: onr:"swepub:oai:lup.lub.lu.se:7b2b5422-14a1-433e-b133-713a1dbd3aac" >
Complete Clinical R...
Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2
-
- Kleef, Ralf (författare)
- Dr. Kleef hyperthermie
-
- Moss, Ralph (författare)
- Cancer Decisions, Lermont
-
- Szasz, A. Marcell (författare)
- Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Clinical Protein Science and Imaging,Forskargrupper vid Lunds universitet,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University Research Groups,Semmelweis University
-
visa fler...
-
- Bohdjalian, Arthur (författare)
- Rudolfinerhaus, Vienna
-
- Bojar, Hans (författare)
- NextGen Oncology Group, Düsseldorf
-
- Bakacs, Tibor (författare)
- PRET Therapeutics Ltd, Budapest
-
visa färre...
-
Dr Kleef hyperthermie Cancer Decisions, Lermont (creator_code:org_t)
- 2018-09-07
- 2018
- Engelska 7 s.
-
Ingår i: Integrative Cancer Therapies. - : SAGE Publications. - 1534-7354 .- 1552-695X. ; 17:4, s. 1297-1303
- Relaterad länk:
-
http://dx.doi.org/10... (free)
-
visa fler...
-
https://journals.sag...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The prognosis of triple-negative breast cancer with metastases after chemotherapy remains dismal. We report the case of a 50-year-old female with first disease recurrence at the axillary lymph node and, later on, bilateral pulmonary metastases with severe shortness of breath. The patient received low-dose immune checkpoint blockade (concurrent nivolumab and ipilimumab) weekly over 3 weeks with regional hyperthermia 3 times a week, followed by systemic fever-range hyperthermia induced by interleukin-2 for 5 days. She went into complete remission of her pulmonary metastases with transient WHO I-II diarrhea and skin rash. The patient remained alive for 27 months after the start of treatment, with recurrence of metastases as a sternal mass, and up to 3 cm pleural metastases. This exceptional response should instigate further research efforts with this protocol, which consists only of approved drugs and treatments.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- checkpoint inhibition
- hyperthermia
- IL-2
- immunotherapy
- TNBC
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas